In spring of 2024, Golden Helix released the first version of the VSPGx pharmacogenomics capability in the VarSeq software. This feature development represents a major milestone in healthcare advancements for personalized genomics. VSPGx provides a rapid yet comprehensive solution for annotating all relevant star alleles and subsequent diplotype calling to report on an individual's response to various drugs. The fundamental goal with VSPGx is to read an individual's genetic profile to then enhance the efficacy of prescribing medications while minimizing adverse reactions. Relevant PGx databases and tools are regularly updated to maintain up-to-date reporting. Thus, our latest version VarSeq 2.6.2 includes further advancements with our VSPGx capabilities. This webcast will provide an introduction to PGx analysis in VarSeq, as well as call attention to recent developments in data import, CYP2D6 calling, and pharmacogenomics reporting.

Highlights of the webcast will include:

Watch on demand

Please enjoy this webcast recording. Should you have any questions about the content covered, please reach out to our team here.